Growth Metrics

Nuwellis (NUWE) Other financing activities (2018 - 2026)

Nuwellis posted quarterly Other financing activities of $25000.0 for Q1 2026, down 62.69% year-on-year from $67000.0 in Q1 2025, and up 4.17% on a QoQ basis from $24000.0 in Q4 2025.

Nuwellis (NUWE) has 9 years of Other financing activities data on file, last reported at $25000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other financing activities fell 62.69% year-over-year to $25000.0; the trailing twelve-month figure through Mar 2026 stood at $85000.0 (down 78.04% YoY), and the FY2025 full-year result was $127000.0, down 73.43% from the prior year.
  • Other financing activities for Q1 2026 stood at $25000.0, up from $24000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $241000.0 in Q1 2022 and bottomed at $17000.0 in Q2 2025.
  • The 5-year median for Other financing activities is $135000.0 (2023), against an average of $127176.5.
  • The widest annual swing landed in 2023, when Other financing activities retreated 4.85%; it then slumped 85.22% in 2025.
  • A 5-year view of Other financing activities shows it stood at $165000.0 in 2022, then fell by 4.85% to $157000.0 in 2023, then sank by 33.76% to $104000.0 in 2024, then sank by 76.92% to $24000.0 in 2025, then grew by 4.17% to $25000.0 in 2026.
  • The last three Other financing activities figures came in at $25000.0 (Q1 2026), $24000.0 (Q4 2025), and $19000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 25,000.00
Mar 31, 2026 25,000.00
Dec 31, 2025 24,000.00
Dec 31, 2025 24,000.00
Sep 30, 2025 19,000.00
Sep 30, 2025 19,000.00
Jun 30, 2025 17,000.00
Jun 30, 2025 17,000.00
Mar 31, 2025 67,000.00
Mar 31, 2025 67,000.00
Dec 31, 2024 104,000.00
Dec 31, 2024 104,000.00
Sep 30, 2024 101,000.00
Sep 30, 2024 101,000.00
Jun 30, 2024 115,000.00
Jun 30, 2024 115,000.00
Mar 31, 2024 158,000.00
Mar 31, 2024 158,000.00
Dec 31, 2023 157,000.00
Dec 31, 2023 157,000.00
Sep 30, 2023 135,000.00
Sep 30, 2023 135,000.00
Jun 30, 2023 197,000.00
Jun 30, 2023 197,000.00
Mar 31, 2023 181,000.00
Mar 31, 2023 181,000.00
Dec 31, 2022 165,000.00
Dec 31, 2022 165,000.00
Sep 30, 2022 220,000.00
Sep 30, 2022 220,000.00
Jun 30, 2022 236,000.00
Jun 30, 2022 236,000.00
Mar 31, 2022 241,000.00
Mar 31, 2022 241,000.00
Dec 31, 2021 321,000.00
Dec 31, 2021 321,000.00
Sep 30, 2021 257,000.00
Sep 30, 2021 257,000.00
Jun 30, 2021 381,000.00
Jun 30, 2021 381,000.00
Mar 31, 2021 355,000.00
Mar 31, 2021 355,000.00
Dec 31, 2020 312,000.00
Dec 31, 2020 312,000.00
Sep 30, 2020 310,000.00
Sep 30, 2020 310,000.00
Jun 30, 2020 347,000.00
Jun 30, 2020 347,000.00
Mar 31, 2020 380,000.00
Mar 31, 2020 380,000.00
Dec 31, 2019 399,000.00
Dec 31, 2019 399,000.00
Sep 30, 2019 412,000.00
Sep 30, 2019 412,000.00
Jun 30, 2019 339,000.00
Jun 30, 2019 339,000.00
Mar 31, 2019 362,000.00
Mar 31, 2019 362,000.00
Dec 31, 2018 543,000.00
Dec 31, 2018 543,000.00
Sep 30, 2018 437,000.00
Sep 30, 2018 437,000.00
Jun 30, 2018 606,000.00
Jun 30, 2018 606,000.00
Mar 31, 2018 501,000.00
Mar 31, 2018 501,000.00